DKDo Young Kim

Do Young Kim

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Do Young Kim has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Molecular epidemiology and clinical differentiation between Clostridioides difficile infection and colonization across three chicago medical centers

    by Andrew M. Skinner, Do Young Kim, Adam Cheknis, Michael Lin, Mary K. Hayden, Nicholas M. Moore, Amanda Harrington, Vera Tesic, Kathleen G. Beavis, Dale N. Gerding, et al.

    In a retrospective cohort study at three Chicago academic medical centers, 22/81 (27.2%) patients with a clinically adjudicated positive C. difficile test result were colonized. Recent antibiotic usage predicted true infection (adjusted odds ratio: 4.38 for infection). Restriction endonuclease analysis(REA) group Y (29.3%) replaced BI (9.3%) as the dominant strain.


  • The Brief Case: Bergeyella zoohelcum Bacteremia in an Immunocompromised 69-Year-Old Patient

    by Tristan R. Grams, Do Young Kim, Erin McElvania

    A 69-year-old male with a history of metastatic prostate cancer on chemotherapy and lymphedema of bilateral lower extremities presented to the emergency department (ED) in septic shock with confusion and weakness. The patient was hypotensive (blood pressure, 69/50 mm/Hg), tachycardic (heart rate, 110 beats per minute), and tachypneic (respiratory rate, 24 breaths per minute) upon presentation to the ED. On physical examination, erythema and tenderness were observed below the left knee to above the ankle, concerning for cellulitis. Computed tomography (CT) imaging of the left lower extremity revealed prominent thickening of the subcutaneous soft tissues but did not show loculated fluid collection, ulceration, or a sinus tract. The patient was admitted to the intensive care unit (ICU) for further care.


  • Open Access

    Genomic Investigation to Identify Sources of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Personnel in an Acute Care Hospital

    by Sarah E Sansom, Hannah Barbian, Mary K Hayden, Christine Fukuda, Nicholas M Moore, Lahari Thotapalli, Elias J Baied, Do Young Kim, Evan Snitkin, Michael Y Lin, et al.

    Background: Identifying the source of healthcare personnel (HCP) coronavirus disease 2019 (COVID-19) is important to guide occupational safety efforts. We used a combined whole genome sequencing (WGS) and epidemiologic approach to investigate the source of HCP COVID-19 at a tertiary-care center early in the COVID-19 pandemic.Methods: Remnant nasopharyngeal swab samples from HCP and patients with polymerase chain reaction–proven COVID-19 from a period with complete sample retention (14 March 2020 to 10 April 2020) at Rush University Medical Center in Chicago, Illinois, underwent viral RNA extraction and WGS. Genomes with >90% coverage underwent cluster detection using a 2 single-nucleotide variant genetic distance cutoff. Genomic clusters were evaluated for epidemiologic linkages, with strong linkages defined by evidence of time/location overlap.Results: We analyzed 1031 sequences, identifying 49 clusters that included ≥1 HCP (265 patients, 115 HCP). Most HCP infections were not healthcare associated (88/115 [76.5%]). We did not identify any strong epidemiologic linkages for patient-to-HCP transmission. Thirteen HCP cases (11.3%) were attributed to a potential patient source (weak evidence involving nonclinical staff that lacked location data to prove or disprove contact with patients in same cluster). Fourteen HCP cases (12.2%) were attributed to HCP source (11 with strong evidence).Conclusions: Using genomic and epidemiologic data, we found that most HCP severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections were not healthcare associated. We did not find strong evidence of patient-to-HCP transmission of SARS-CoV-2.


  • Open Access

    Duration of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Shedding Among Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)

    by Do Young Kim, Michael Y Lin, Cheryl Jennings, Haiying Li, Jae Hyung Jung, Nicholas M Moore, Isaac Ghinai, Stephanie R Black, Daniel J Zaccaro, John Brofman, et al.

    Patterns of shedding replication-competent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in severe or critical COVID-19 are not well characterized. We investigated the duration of replication-competent SARS-CoV-2 shedding in upper and lower airway specimens from patients with severe or critical coronavirus disease 2019 (COVID-19). We enrolled patients with active or recent severe or critical COVID-19 who were admitted to a tertiary care hospital intensive care unit (ICU) or long-term acute care hospital (LTACH) because of COVID-19. Respiratory specimens were collected at predefined intervals and tested for SARS-CoV-2 using viral culture and reverse transcription–quantitative polymerase chain reaction (RT-qPCR). Clinical and epidemiologic metadata were reviewed. We collected 529 respiratory specimens from 78 patients. Replication-competent virus was detected in 4 of 11 (36.3%) immunocompromised patients up to 45 days after symptom onset and in 1 of 67 (1.5%) immunocompetent patients 10 days after symptom onset (P = .001). All culture-positive patients were in the ICU cohort and had persistent or recurrent symptoms of COVID-19. Median time from symptom onset to first specimen collection was 15 days (range, 6–45) for ICU patients and 58.5 days (range, 34–139) for LTACH patients. SARS-CoV-2 RNA was detected in 40 of 50 (80%) ICU patients and 7 of 28 (25%) LTACH patients. Immunocompromise and persistent or recurrent symptoms were associated with shedding of replication-competent SARS-CoV-2, supporting the need for improving respiratory symptoms in addition to time as criteria for discontinuation of transmission-based precautions. Our results suggest that the period of potential infectiousness among immunocompetent patients with severe or critical COVID-19 may be similar to that reported for patients with milder disease.